Fresita Proteins Limited will convene a Rights Issue Committee meeting on Monday, October 26, 2026, to determine the specific terms of its proposed rights issue. The company plans to raise up to ₹90 crore through the issuance of equity shares with a face value of ₹10 each.

The committee will discuss and decide on critical parameters including the rights issue price, payment mechanism, rights entitlement ratio, and the record date. These details will be finalized in accordance with the Companies Act, 2013, and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Trading window closure

In compliance with the company's Code of Conduct for Prevention of Insider Trading, the trading window for Fresita Proteins equity shares will remain closed from October 26, 2026, until 48 hours after the conclusion of the board meeting. This restriction applies to directors, designated persons, and their immediate relatives.

Background on capital raise

This development follows the Board of Directors' approval on August 5, 2026, regarding the rights issue. The intimation was filed with BSE Limited under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Fresita Proteins Limited shareholders approved a special resolution authorizing borrowing powers up to ₹1,000 crore during the Annual General Meeting (AGM) held on September 30, 2026. The company, formerly known as Sarda Proteins Limited, also received unanimous consent for loans, guarantees, and investments up to the same amount under Section 186 of the Companies Act, 2013.

The meeting was conducted via Video Conferencing/Other Audio Visual Means (VC/OAVM) in compliance with SEBI Listing Regulations. All five resolutions listed in the notice were passed with 100% votes in favour. The scrutinizer’s report confirmed that no votes were cast against any of the proposed items.

Voting Results

The voting process involved remote e-voting through NSDL and CDSL platforms, as well as e-voting during the AGM. A total of 12 members participated, casting votes for 7,243,317 shares. The turnout represented full support for the management's proposals.

Governance and Audit Updates

Shareholders ratified the appointment of M/s. A H Mandaliya & Associates, Chartered Accountants, as the Statutory Auditors of the company. Additionally, Mr. Shivam Gunvantray Zaladi (DIN: 11251860), who retired by rotation, was re-appointed as a director following his eligibility confirmation.

The AGM notice was issued on September 7, 2026, with the cut-off date for entitlement to vote set at September 23, 2026. The remote e-voting period commenced on September 26, 2026, and concluded on September 29, 2026.

What the Numbers Show

The data reveals a highly concentrated shareholder base with minimal dissent. Only 12 members voted on behalf of over 7.2 million shares, indicating that the participating equity likely represents a significant portion of the company's active voting stock or that major promoters hold a dominant stake. The unanimous passage of high-value financial authorizations, specifically the ₹1,000 crore limits for both borrowing and investments, suggests strong alignment between the board and the voting shareholders regarding the company's future capital allocation strategy.